Home › Companies › BeOne Medicines Ltd. › 2025-2026

BeOne Medicines Ltd. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and BeOne Medicines Ltd.’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.

80Reported items
404Asset managers
9,277Fund votes
2026-06-11Meeting date

Proxy season: 2025-2026

Explore BeOne Medicines Ltd. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by BeOne Medicines Ltd.

These tallies are BeOne Medicines Ltd.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BeOne Medicines Ltd. — official shareholder meeting results, meeting held 2026-06-11
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Dr. Olivier Brandicourt	1,022,508,944	5,736,979	32,780,986	--	--	Majority: yes
Elect Director: Dr. Margaret Dugan	1,011,658,169	16,567,756	32,794,584	--	--	Majority: yes
Elect Director: Mr. Anthony C. Hooper	997,703,483	29,570,339	33,746,687	--	--	Majority: yes
Elect Director: Mr. John V. Oyler	1,013,945,040	12,727,593	34,347,876	--	--	Majority: yes
Elect Director: Dr. Alessandro Riva	708,200,626	320,024,909	32,794,974	--	--	Majority: yes
Elect Director: Ms. Shalini Sharp	998,811,368	28,636,943	33,572,198	--	--	Majority: yes
Elect Director: Dr. Xiaodong Wang	1,022,595,038	5,650,686	32,774,785	--	--	Majority: yes
Elect Director: Dr. Felix J. Baker	856,267,633	171,971,786	32,781,090	--	--	Majority: yes
Elect Director: Ms. Elizabeth F. Mooney	1,028,073,956	152,008	32,794,545	--	--	Majority: yes
Elect Director: Dr. Charles L. Sawyers	1,028,075,907	146,090	32,804,912	--	--	Majority: yes
Elect Director: Dr. Margaret Dugan	1,012,836,634	15,408,489	32,781,786	--	--	Majority: yes
Elect Director: Ms. Elizabeth F. Mooney	1,028,055,025	172,249	32,799,635	--	--	Majority: yes
Accordingly, the Amended 2016 Plan was approved. (15)(b) Proposal to approve the consultant sublimit set out in the Amended 2016 Plan, as described in the Proxy Statement:	854,739,119	111,218,786	95,062,604	--	--	Majority: yes
Proposal to approve the Amended 2018 ESPP, as described in the Proxy Statement:	963,591,745	2,384,295	95,044,469	--	--	Majority: yes

Source: BeOne Medicines Ltd., Form 8-K — read the filing on EDGAR.

How asset managers voted at the BeOne Medicines Ltd. 2025-2026 meeting

Each item below shows how the 404 asset managers that disclosed a BeOne Medicines Ltd. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BeOne Medicines Ltd.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. THAT, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT, FOR THE FISCAL YEAR ENDED DECEMBER 31, 2025 BE AND IS HEREBY APPROVED.

SECTION 14A SAY-ON-PAY VOTES

Combines 10 wordings of this item as funds reported it.

85% fund support · no official result

FOR 85%AGAINST 15%

The 381 asset managers below cast 85% of the shares they voted on this item FOR (221,104,702 for, 38,403,658 against).

FOR: 221,104,702 (85.1%)AGAINST: 38,403,658 (14.8%)ABSTAIN: 51 (0.0%)NOT VOTED: 290,172 (0.1%)

Largest asset managers voting on “THAT, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOS” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
Vanguard	38,753,063	0	For
Capital Group	23,552,321	0	For
Fidelity	15,246,397	355,700	For
HHLR ADVISORS, LTD.	14,807,926	0	For
BAILLIE GIFFORD OVERSEAS LTD	11,723,127	0	For
State Street	11,474,311	13,442	For
BAKER BROS. ADVISORS LP	8,942,864	0	For
T. Rowe Price	7,945,574	63,711	For
Goldman Sachs	6,398,160	0	For
PRIMECAP MANAGEMENT CO/CA/	4,945,783	0	For
Robeco Institutional Asset Management B.V.	0	4,777,456	Against
BAILLIE GIFFORD & CO	4,683,934	0	For
Baillie Gifford Investment Management (Europe) Ltd	4,511,953	0	For
HSBC	0	4,386,679	Against
Legal & General Investment Management Ltd	0	4,198,934	Against
Hang Seng Investment Management Ltd	0	4,048,801	Against
Nuveen	4,042,991	0	For
TIAA	3,901,731	0	For
AustralianSuper Pty Ltd	0	3,510,755	Against
UBS	0	3,239,232	Against
BlackRock	3,169,697	0	For
Hartford	3,041,800	0	For
BAILLIE GIFFORD FUNDS	3,010,304	0	For
Connor, Clark & Lunn Investment Management Ltd.	2,664,835	0	For
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	0	2,225,611	Against

Showing the 25 largest of 381 asset managers. See all 381 in the interactive database.

2. THAT, ON AN ADVISORY BASIS, THE SWISS STATUTORY COMPENSATION REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2025 BE AND IS HEREBY APPROVED.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

99.5% fund support · no official result

FOR 99.5%

The 97 asset managers below cast 99.5% of the shares they voted on this item FOR (99,723,417 for, 478,286 against).

FOR: 99,723,417 (99.5%)AGAINST: 478,286 (0.5%)ABSTAIN: 27 (0.0%)

Largest asset managers voting on “THAT, ON AN ADVISORY BASIS, THE SWISS STATUTORY COMPENSATION REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 202” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
Vanguard	29,042,676	0	For
BAILLIE GIFFORD OVERSEAS LTD	11,723,127	0	For
Capital Group	10,071,735	0	For
Fidelity	6,806,774	0	For
BAILLIE GIFFORD & CO	4,683,929	0	For
Baillie Gifford Investment Management (Europe) Ltd	4,511,953	0	For
TIAA	3,897,446	0	For
T. Rowe Price	3,247,430	20,800	For
BlackRock	3,169,697	0	For
Hartford	3,041,800	0	For
BAILLIE GIFFORD FUNDS	3,010,304	0	For
BAILLIE GIFFORD & CO LTD	2,221,019	0	For
Goldman Sachs	1,964,090	0	For
State Street	1,815,419	0	For
Delaware/Macquarie	1,783,500	0	For
PRIMECAP Odyssey Funds	1,246,404	0	For
Charles Schwab	979,581	0	For
EUPAC FUND	700,821	0	For
Dimensional	490,710	0	For
Siren, L.L.C.	465,000	0	For
Korea Investment CORP	0	360,900	Against
Northern Trust	343,378	0	For
Pacific Life	328,000	0	For
WisdomTree	326,022	0	For
Krane Shares Trust	297,118	0	For

Showing the 25 largest of 97 asset managers. See all 97 in the interactive database.

3. THAT, THE MAXIMUM AGGREGATE COMPENSATION FOR THE EXECUTIVE MANAGEMENT TEAM FOR FISCAL YEAR 2027 BE AND IS HEREBY APPROVED.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 89 asset managers below cast 99.9% of the shares they voted on this item FOR (74,199,630 for, 57,258 against).

FOR: 74,199,630 (99.9%)AGAINST: 57,258 (0.1%)ABSTAIN: 27 (0.0%)

Largest asset managers voting on “THAT, THE MAXIMUM AGGREGATE COMPENSATION FOR THE EXECUTIVE MANAGEMENT TEAM FOR FISCAL YEAR 2027 BE AND IS HERE” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
BlackRock	944,077	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Siren, L.L.C.	465,000	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

4. THAT the Board of Directors is hereby authorized to fix the auditors' compensation for the fiscal year ending December 31, 2026.

AUDIT-RELATED

Combines 5 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 86 asset managers below cast 100% of the shares they voted on this item FOR (73,788,995 for, 0 against).

FOR: 73,788,995 (100.0%)

Largest asset managers voting on “THAT the Board of Directors is hereby authorized to fix the auditors' compensation for the fiscal year ending ” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
BlackRock	944,077	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 86 asset managers. See all 86 in the interactive database.

5. THAT, the maximum aggregate compensation for the Board of Directors for the period between the 2026 annual general meeting and the 2027 annual general meeting, be and is hereby approved.

COMPENSATION

Combines 3 wordings of this item as funds reported it.

99.2% fund support · no official result

FOR 99.2%

The 86 asset managers below cast 99.2% of the shares they voted on this item FOR (73,255,071 for, 532,718 against).

FOR: 73,255,071 (99.3%)AGAINST: 532,718 (0.7%)

Largest asset managers voting on “THAT, the maximum aggregate compensation for the Board of Directors for the period between the 2026 annual gen” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
Vanguard	29,042,676	0	For
Capital Group	10,071,735	0	For
Fidelity	6,806,774	0	For
TIAA	3,897,446	0	For
T. Rowe Price	3,247,430	20,800	For
Hartford	3,041,800	0	For
BAILLIE GIFFORD FUNDS	3,010,304	0	For
Goldman Sachs	1,964,090	0	For
State Street	1,815,419	0	For
Delaware/Macquarie	1,783,500	0	For
PRIMECAP Odyssey Funds	1,246,404	0	For
Charles Schwab	979,581	0	For
BlackRock	944,077	0	For
EUPAC FUND	700,821	0	For
Dimensional	490,710	0	For
Pacific Life	328,000	0	For
WisdomTree	326,022	0	For
Krane Shares Trust	297,118	0	For
John Hancock	271,347	0	For
Lord Abbett	256,213	0	For
Baird	255,828	0	For
First Trust	249,459	0	For
Northern Trust	217,039	0	For
NEW ECONOMY FUND	186,309	0	For
Nationwide	173,700	0	For

Showing the 25 largest of 86 asset managers. See all 86 in the interactive database.

6. THAT Dr. Alessandro Riva be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

69% Majority: yes · of votes cast

FOR 69%AGAINST 31%

FOR: 708,200,626AGAINST: 320,024,909

BeOne Medicines Ltd.’s own tally for this item (“Elect Director: Dr. Alessandro Riva”): 708,200,626 for, 320,024,909 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,445,262,342 outstanding shares: 49.0% for, 22% against (71% of the company cast a for/against vote).

The 85 asset managers below cast 26% of the shares they voted on this item FOR (24,718,520 for, 71,280,076 against).

FOR 26%AGAINST 74%

FOR: 24,718,520 (25.7%)AGAINST: 71,280,076 (74.3%)

Largest asset managers voting on “THAT Dr. Alessandro Riva be and is hereby re-elected to serve as a director of the Company for a term extendin” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
Vanguard	3,672,143	25,370,533	Against
BlackRock	0	22,930,390	Against
Capital Group	10,071,735	0	For
Fidelity	652,400	6,154,374	Against
TIAA	0	3,897,446	Against
T. Rowe Price	0	3,268,230	Against
Hartford	2,853,600	188,200	For
BAILLIE GIFFORD FUNDS	3,010,304	0	For
Goldman Sachs	0	1,964,090	Against
State Street	1,815,419	0	For
Delaware/Macquarie	0	1,783,500	Against
PRIMECAP Odyssey Funds	1,246,404	0	For
Charles Schwab	0	979,581	Against
EUPAC FUND	700,821	0	For
Dimensional	0	490,710	Against
Pacific Life	0	328,000	Against
WisdomTree	0	326,022	Against
Krane Shares Trust	0	297,118	Against
John Hancock	30,500	240,847	Against
Lord Abbett	0	256,213	Against
Baird	0	255,828	Against
First Trust	0	249,459	Against
Northern Trust	0	217,039	Against
NEW ECONOMY FUND	186,309	0	For
Nationwide	0	173,700	Against

Showing the 25 largest of 85 asset managers. See all 85 in the interactive database.

7. THAT Dr. Charles L. Sawyers be and is hereby elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 1,028,075,907AGAINST: 146,090

BeOne Medicines Ltd.’s own tally for this item (“Elect Director: Dr. Charles L. Sawyers”): 1,028,075,907 for, 146,090 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,445,262,342 outstanding shares: 71% for, 0.1% against (71% of the company cast a for/against vote).

The 85 asset managers below cast 100% of the shares they voted on this item FOR (95,998,596 for, 0 against).

FOR 100%

FOR: 95,998,596 (100.0%)

Largest asset managers voting on “THAT Dr. Charles L. Sawyers be and is hereby elected to serve as a director of the Company for a term extendin” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
BlackRock	22,930,390	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 85 asset managers. See all 85 in the interactive database.

8. THAT Dr. Felix J. Baker be and is hereby elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST 17%

FOR: 856,267,633AGAINST: 171,971,786

BeOne Medicines Ltd.’s own tally for this item (“Elect Director: Dr. Felix J. Baker”): 856,267,633 for, 171,971,786 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,445,262,342 outstanding shares: 59% for, 12% against (71% of the company cast a for/against vote).

The 85 asset managers below cast 66% of the shares they voted on this item FOR (63,162,675 for, 32,835,921 against).

FOR 66%AGAINST 34%

FOR: 63,162,675 (65.8%)AGAINST: 32,835,921 (34.2%)

Largest asset managers voting on “THAT Dr. Felix J. Baker be and is hereby elected to serve as a director of the Company for a term extending un” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
Vanguard	29,033,292	9,384	For
BlackRock	12,341	22,918,049	Against
Capital Group	3,476,098	6,595,637	Against
Fidelity	6,806,774	0	For
TIAA	3,897,446	0	For
T. Rowe Price	3,268,230	0	For
Hartford	2,853,600	188,200	For
BAILLIE GIFFORD FUNDS	3,010,304	0	For
Goldman Sachs	1,964,090	0	For
State Street	1,815,419	0	For
Delaware/Macquarie	0	1,783,500	Against
PRIMECAP Odyssey Funds	1,246,404	0	For
Charles Schwab	979,581	0	For
EUPAC FUND	112,332	588,489	Against
Dimensional	490,710	0	For
Pacific Life	328,000	0	For
WisdomTree	326,022	0	For
Krane Shares Trust	297,118	0	For
John Hancock	271,347	0	For
Lord Abbett	256,213	0	For
Baird	255,828	0	For
First Trust	249,459	0	For
Northern Trust	0	217,039	Against
NEW ECONOMY FUND	186,309	0	For
Nationwide	135,500	38,200	For

Showing the 25 largest of 85 asset managers. See all 85 in the interactive database.

9. THAT Dr. Olivier Brandicourt be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 1,022,508,944AGAINST: 5,736,979

BeOne Medicines Ltd.’s own tally for this item (“Elect Director: Dr. Olivier Brandicourt”): 1,022,508,944 for, 5,736,979 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,445,262,342 outstanding shares: 71% for, 0.4% against (71% of the company cast a for/against vote).

The 85 asset managers below cast 100% of the shares they voted on this item FOR (95,998,596 for, 0 against).

FOR 100%

FOR: 95,998,596 (100.0%)

Largest asset managers voting on “THAT Dr. Olivier Brandicourt be and is hereby re-elected to serve as a director of the Company for a term exte” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
BlackRock	22,930,390	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 85 asset managers. See all 85 in the interactive database.

10. THAT Dr. Xiaodong Wang be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 1,022,595,038AGAINST: 5,650,686

BeOne Medicines Ltd.’s own tally for this item (“Elect Director: Dr. Xiaodong Wang”): 1,022,595,038 for, 5,650,686 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,445,262,342 outstanding shares: 71% for, 0.4% against (71% of the company cast a for/against vote).

The 85 asset managers below cast 100% of the shares they voted on this item FOR (95,998,596 for, 0 against).

FOR 100%

FOR: 95,998,596 (100.0%)

Largest asset managers voting on “THAT Dr. Xiaodong Wang be and is hereby re-elected to serve as a director of the Company for a term extending ” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
BlackRock	22,930,390	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 85 asset managers. See all 85 in the interactive database.

11. THAT Mr. Anthony C. Hooper be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 997,703,483AGAINST: 29,570,339

BeOne Medicines Ltd.’s own tally for this item (“Elect Director: Mr. Anthony C. Hooper”): 997,703,483 for, 29,570,339 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,445,262,342 outstanding shares: 69% for, 2% against (71% of the company cast a for/against vote).

The 85 asset managers below cast 98% of the shares they voted on this item FOR (94,001,231 for, 1,997,365 against).

FOR 98%

FOR: 94,001,231 (97.9%)AGAINST: 1,997,365 (2.1%)

Largest asset managers voting on “THAT Mr. Anthony C. Hooper be and is hereby re-elected to serve as a director of the Company for a term extend” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
Vanguard	29,042,676	0	For
BlackRock	22,930,390	0	For
Capital Group	10,071,735	0	For
Fidelity	6,806,774	0	For
TIAA	3,897,446	0	For
T. Rowe Price	3,268,230	0	For
Hartford	3,041,800	0	For
BAILLIE GIFFORD FUNDS	3,010,304	0	For
Goldman Sachs	1,964,090	0	For
State Street	0	1,815,419	Against
Delaware/Macquarie	1,783,500	0	For
PRIMECAP Odyssey Funds	1,246,404	0	For
Charles Schwab	979,581	0	For
EUPAC FUND	700,821	0	For
Dimensional	490,710	0	For
Pacific Life	328,000	0	For
WisdomTree	326,022	0	For
Krane Shares Trust	297,118	0	For
John Hancock	240,847	30,500	For
Lord Abbett	256,213	0	For
Baird	255,828	0	For
First Trust	249,459	0	For
Northern Trust	217,039	0	For
NEW ECONOMY FUND	186,309	0	For
Nationwide	173,700	0	For

Showing the 25 largest of 85 asset managers. See all 85 in the interactive database.

12. THAT Mr. John V. Oyler be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 1,013,945,040AGAINST: 12,727,593

BeOne Medicines Ltd.’s own tally for this item (“Elect Director: Mr. John V. Oyler”): 1,013,945,040 for, 12,727,593 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,445,262,342 outstanding shares: 70% for, 0.9% against (71% of the company cast a for/against vote).

The 85 asset managers below cast 99.9% of the shares they voted on this item FOR (95,981,431 for, 15,000 against).

FOR 99.9%

FOR: 95,981,431 (100.0%)AGAINST: 15,000 (0.0%)

Largest asset managers voting on “THAT Mr. John V. Oyler be and is hereby re-elected to serve as a director of the Company for a term extending ” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
BlackRock	22,928,749	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 85 asset managers. See all 85 in the interactive database.

13. THAT Ms. Shalini Sharp be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 998,811,368AGAINST: 28,636,943

BeOne Medicines Ltd.’s own tally for this item (“Elect Director: Ms. Shalini Sharp”): 998,811,368 for, 28,636,943 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,445,262,342 outstanding shares: 69% for, 2% against (71% of the company cast a for/against vote).

The 85 asset managers below cast 96% of the shares they voted on this item FOR (92,389,632 for, 3,608,964 against).

FOR 96%

FOR: 92,389,632 (96.2%)AGAINST: 3,608,964 (3.8%)

Largest asset managers voting on “THAT Ms. Shalini Sharp be and is hereby re-elected to serve as a director of the Company for a term extending ” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
Vanguard	29,033,292	9,384	For
BlackRock	22,930,390	0	For
Capital Group	10,071,735	0	For
Fidelity	6,806,774	0	For
TIAA	3,897,446	0	For
T. Rowe Price	0	3,268,230	Against
Hartford	2,853,600	188,200	For
BAILLIE GIFFORD FUNDS	3,010,304	0	For
Goldman Sachs	1,964,090	0	For
State Street	1,815,419	0	For
Delaware/Macquarie	1,783,500	0	For
PRIMECAP Odyssey Funds	1,246,404	0	For
Charles Schwab	979,581	0	For
EUPAC FUND	700,821	0	For
Dimensional	490,710	0	For
Pacific Life	328,000	0	For
WisdomTree	326,022	0	For
Krane Shares Trust	297,118	0	For
John Hancock	210,549	60,798	For
Lord Abbett	256,213	0	For
Baird	255,828	0	For
First Trust	249,459	0	For
Northern Trust	217,039	0	For
NEW ECONOMY FUND	186,309	0	For
Nationwide	173,700	0	For

Showing the 25 largest of 85 asset managers. See all 85 in the interactive database.

14. THAT the consultant sublimit in the Fifth Amended and Restated 2016 Share Option and Incentive Plan be and is hereby approved.

COMPENSATION

Combines 3 wordings of this item as funds reported it.

85% fund support · no official result

FOR 85%AGAINST 15%

The 85 asset managers below cast 85% of the shares they voted on this item FOR (62,807,809 for, 10,976,875 against).

FOR: 62,807,809 (85.1%)AGAINST: 10,976,875 (14.9%)

Largest asset managers voting on “THAT the consultant sublimit in the Fifth Amended and Restated 2016 Share Option and Incentive Plan be and is ” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
Vanguard	29,042,676	0	For
Capital Group	0	10,071,735	Against
Fidelity	6,806,774	0	For
TIAA	3,897,446	0	For
T. Rowe Price	3,268,230	0	For
Hartford	3,041,800	0	For
BAILLIE GIFFORD FUNDS	3,010,304	0	For
Goldman Sachs	1,964,090	0	For
State Street	1,815,419	0	For
Delaware/Macquarie	1,783,500	0	For
PRIMECAP Odyssey Funds	1,246,404	0	For
Charles Schwab	979,581	0	For
BlackRock	944,077	0	For
EUPAC FUND	0	700,821	Against
Dimensional	490,710	0	For
Pacific Life	328,000	0	For
WisdomTree	326,022	0	For
Krane Shares Trust	297,118	0	For
John Hancock	271,347	0	For
Lord Abbett	256,213	0	For
Baird	255,828	0	For
First Trust	249,459	0	For
Northern Trust	217,039	0	For
NEW ECONOMY FUND	0	186,309	Against
Nationwide	173,700	0	For

Showing the 25 largest of 85 asset managers. See all 85 in the interactive database.

15. THAT the Fifth Amended and Restated 2016 Share Option and Incentive Plan be and is hereby approved.

COMPENSATION

Combines 3 wordings of this item as funds reported it.

84% fund support · no official result

FOR 84%AGAINST 16%

The 85 asset managers below cast 84% of the shares they voted on this item FOR (62,213,043 for, 11,571,641 against).

FOR: 62,213,043 (84.3%)AGAINST: 11,571,641 (15.7%)

Largest asset managers voting on “THAT the Fifth Amended and Restated 2016 Share Option and Incentive Plan be and is hereby approved.” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
Vanguard	29,042,676	0	For
Capital Group	10,071,735	0	For
Fidelity	6,806,774	0	For
TIAA	0	3,897,446	Against
T. Rowe Price	0	3,268,230	Against
Hartford	3,041,800	0	For
BAILLIE GIFFORD FUNDS	3,010,304	0	For
Goldman Sachs	1,964,090	0	For
State Street	1,815,419	0	For
Delaware/Macquarie	0	1,783,500	Against
PRIMECAP Odyssey Funds	1,246,404	0	For
Charles Schwab	979,581	0	For
BlackRock	944,077	0	For
EUPAC FUND	700,821	0	For
Dimensional	0	490,710	Against
Pacific Life	328,000	0	For
WisdomTree	326,022	0	For
Krane Shares Trust	297,118	0	For
John Hancock	30,500	240,847	Against
Lord Abbett	256,213	0	For
Baird	0	255,828	Against
First Trust	0	249,459	Against
Northern Trust	217,039	0	For
NEW ECONOMY FUND	186,309	0	For
Nationwide	135,500	38,200	For

Showing the 25 largest of 85 asset managers. See all 85 in the interactive database.

16. THAT the Sixth Amended and Restated 2018 Employee Share Purchase Plan be and is hereby approved.

COMPENSATION

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 84 asset managers below cast 100% of the shares they voted on this item FOR (73,784,680 for, 0 against).

FOR: 73,784,680 (100.0%)

Largest asset managers voting on “THAT the Sixth Amended and Restated 2018 Employee Share Purchase Plan be and is hereby approved.” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
BlackRock	944,077	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 84 asset managers. See all 84 in the interactive database.

17. THAT Dr. Margaret Dugan be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.

DIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 83 asset managers below cast 100% of the shares they voted on this item FOR (73,782,990 for, 0 against).

FOR: 73,782,990 (100.0%)

Largest asset managers voting on “THAT Dr. Margaret Dugan be and is hereby re-elected to serve as a director of the Company for a term extending” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
BlackRock	944,077	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

18. THAT Dr. Margaret Dugan be and is hereby re-elected to serve as a member of the Compensation Committee of the Company for a term extending until completion of the 2027 annual general meeting.

DIRECTOR ELECTIONSCORPORATE GOVERNANCE

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 83 asset managers below cast 100% of the shares they voted on this item FOR (73,782,990 for, 0 against).

FOR: 73,782,990 (100.0%)

Largest asset managers voting on “THAT Dr. Margaret Dugan be and is hereby re-elected to serve as a member of the Compensation Committee of the ” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
BlackRock	944,077	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

19. THAT Mr. John V. Oyler be and is hereby re-elected to serve as Chairman of the Board of Directors of the Company for a term extending until completion of the 2027 annual general meeting.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 1,013,945,040AGAINST: 12,727,593

The 83 asset managers below cast 94% of the shares they voted on this item FOR (69,522,789 for, 4,260,201 against).

FOR 94%

FOR: 69,522,789 (94.2%)AGAINST: 4,260,201 (5.8%)

Largest asset managers voting on “THAT Mr. John V. Oyler be and is hereby re-elected to serve as Chairman of the Board of Directors of the Compa” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
Vanguard	29,042,676	0	For
Capital Group	10,071,735	0	For
Fidelity	6,806,774	0	For
TIAA	3,897,446	0	For
T. Rowe Price	3,247,430	20,800	For
Hartford	3,041,800	0	For
BAILLIE GIFFORD FUNDS	3,010,304	0	For
Goldman Sachs	1,964,090	0	For
State Street	1,815,419	0	For
Delaware/Macquarie	0	1,783,500	Against
PRIMECAP Odyssey Funds	1,246,404	0	For
Charles Schwab	979,581	0	For
BlackRock	944,077	0	For
EUPAC FUND	700,821	0	For
Dimensional	0	490,710	Against
Pacific Life	328,000	0	For
WisdomTree	326,022	0	For
Krane Shares Trust	297,118	0	For
John Hancock	91,298	180,049	Against
Lord Abbett	256,213	0	For
Baird	0	255,828	Against
First Trust	0	249,459	Against
Northern Trust	0	217,039	Against
NEW ECONOMY FUND	186,309	0	For
Nationwide	173,700	0	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

20. THAT Ms. Elizabeth F. Mooney be and is hereby elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.

DIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 83 asset managers below cast 100% of the shares they voted on this item FOR (73,782,990 for, 0 against).

FOR: 73,782,990 (100.0%)

Largest asset managers voting on “THAT Ms. Elizabeth F. Mooney be and is hereby elected to serve as a director of the Company for a term extendi” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
BlackRock	944,077	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

21. THAT Ms. Elizabeth F. Mooney be and is hereby elected to serve as a member of the Compensation Committee of the Company for a term extending until completion of the 2027 annual general meeting.

DIRECTOR ELECTIONSCORPORATE GOVERNANCE

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 83 asset managers below cast 100% of the shares they voted on this item FOR (73,782,990 for, 0 against).

FOR: 73,782,990 (100.0%)

Largest asset managers voting on “THAT Ms. Elizabeth F. Mooney be and is hereby elected to serve as a member of the Compensation Committee of th” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
BlackRock	944,077	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

22. THAT Schweiger Advokatur/Notariat be and is hereby elected to serve as the Independent Voting Representative for a one-year term ending at the closing of the 2027 annual general meeting of shareholders, including any extraordinary general meeting of shareholders prior to the 2027 annual general meeting of shareholders.

CORPORATE GOVERNANCE

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 83 asset managers below cast 100% of the shares they voted on this item FOR (73,782,990 for, 0 against).

FOR: 73,782,990 (100.0%)

Largest asset managers voting on “THAT Schweiger Advokatur/Notariat be and is hereby elected to serve as the Independent Voting Representative f” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
BlackRock	944,077	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

23. THAT the adjournment of the Annual Meeting by the chairman, if necessary, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to approve any of the proposals described above, be and is hereby approved.

CORPORATE GOVERNANCE

Combines 3 wordings of this item as funds reported it.

34% fund support · no official result

FOR 34%AGAINST 66%

The 83 asset managers below cast 34% of the shares they voted on this item FOR (24,774,789 for, 48,953,601 against).

FOR: 24,774,789 (33.6%)AGAINST: 48,953,601 (66.4%)

Largest asset managers voting on “THAT the adjournment of the Annual Meeting by the chairman, if necessary, to solicit additional proxies if the” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
Vanguard	3,681,527	25,361,149	Against
Capital Group	10,071,735	0	For
Fidelity	652,400	6,154,374	Against
TIAA	0	3,897,446	Against
T. Rowe Price	0	3,268,230	Against
Hartford	3,041,800	0	For
BAILLIE GIFFORD FUNDS	3,010,304	0	For
Goldman Sachs	0	1,964,090	Against
State Street	0	1,815,419	Against
Delaware/Macquarie	0	1,783,500	Against
PRIMECAP Odyssey Funds	1,246,404	0	For
Charles Schwab	979,581	0	For
BlackRock	0	944,077	Against
EUPAC FUND	700,821	0	For
Dimensional	0	490,710	Against
Pacific Life	0	328,000	Against
WisdomTree	326,022	0	For
Krane Shares Trust	297,118	0	For
John Hancock	0	271,347	Against
Lord Abbett	0	256,213	Against
Baird	0	255,828	Against
First Trust	0	249,459	Against
Northern Trust	0	217,039	Against
NEW ECONOMY FUND	186,309	0	For
Nationwide	0	173,700	Against

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

24. THAT the appropriation of the accumulated loss for fiscal year 2025 be and is hereby approved.

CAPITAL STRUCTURE

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 83 asset managers below cast 100% of the shares they voted on this item FOR (73,782,990 for, 0 against).

FOR: 73,782,990 (100.0%)

Largest asset managers voting on “THAT the appropriation of the accumulated loss for fiscal year 2025 be and is hereby approved.” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
BlackRock	944,077	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

25. THAT the audited Swiss statutory standalone financial statements and the audited Swiss statutory consolidated financial statements of the Company for fiscal year 2025 be and are hereby approved.

CORPORATE GOVERNANCE

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 83 asset managers below cast 100% of the shares they voted on this item FOR (73,782,990 for, 0 against).

FOR: 73,782,990 (100.0%)

Largest asset managers voting on “THAT the audited Swiss statutory standalone financial statements and the audited Swiss statutory consolidated ” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
BlackRock	944,077	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

26. THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to Amgen Inc. ("Amgen"), up to a maximum amount of shares in order to maintain the same shareholding percentage of Amgen (based on the then-outstanding share capital of the Company) before and after the allocation of the corresponding securities issued pursuant to an offering conducted pursuan

CAPITAL STRUCTURE

Combines 5 wordings of this item as funds reported it.

53.4% fund support · no official result

FOR 53.4%AGAINST 46.6%

The 83 asset managers below cast 53.4% of the shares they voted on this item FOR (39,381,773 for, 34,401,217 against).

FOR: 39,381,773 (53.4%)AGAINST: 34,401,217 (46.6%)

Largest asset managers voting on “THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to A” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
Vanguard	29,033,292	9,384	For
Capital Group	0	10,071,735	Against
Fidelity	0	6,806,774	Against
TIAA	0	3,897,446	Against
T. Rowe Price	0	3,268,230	Against
Hartford	0	3,041,800	Against
BAILLIE GIFFORD FUNDS	3,010,304	0	For
Goldman Sachs	1,964,090	0	For
State Street	1,815,419	0	For
Delaware/Macquarie	0	1,783,500	Against
PRIMECAP Odyssey Funds	1,246,404	0	For
Charles Schwab	0	979,581	Against
BlackRock	941,977	2,100	For
EUPAC FUND	0	700,821	Against
Dimensional	0	490,710	Against
Pacific Life	328,000	0	For
WisdomTree	326,022	0	For
Krane Shares Trust	0	297,118	Against
John Hancock	30,500	240,847	Against
Lord Abbett	0	256,213	Against
Baird	0	255,828	Against
First Trust	0	249,459	Against
Northern Trust	0	217,039	Against
NEW ECONOMY FUND	0	186,309	Against
Nationwide	135,500	38,200	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

27. THAT the granting of a share issue mandate to the Board of Directors to issue, allot or deal with unissued ordinary shares and/or American Depositary Shares ("ADSs") (including any sale or transfer of treasury shares out of treasury) not exceeding 20% of the total number of issued shares of the Company (excluding treasury shares) as of the date of passing of this resolution up to the next annual g

CAPITAL STRUCTURE

Combines 5 wordings of this item as funds reported it.

62% fund support · no official result

FOR 62%AGAINST 38%

The 83 asset managers below cast 62% of the shares they voted on this item FOR (45,625,578 for, 28,157,412 against).

FOR: 45,625,578 (61.8%)AGAINST: 28,157,412 (38.2%)

Largest asset managers voting on “THAT the granting of a share issue mandate to the Board of Directors to issue, allot or deal with unissued ord” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
Vanguard	29,033,292	9,384	For
Capital Group	6,595,637	3,476,098	For
Fidelity	0	6,806,774	Against
TIAA	0	3,897,446	Against
T. Rowe Price	0	3,268,230	Against
Hartford	0	3,041,800	Against
BAILLIE GIFFORD FUNDS	3,010,304	0	For
Goldman Sachs	1,964,090	0	For
State Street	1,815,419	0	For
Delaware/Macquarie	0	1,783,500	Against
PRIMECAP Odyssey Funds	1,246,404	0	For
Charles Schwab	0	979,581	Against
BlackRock	0	944,077	Against
EUPAC FUND	588,489	112,332	For
Dimensional	0	490,710	Against
Pacific Life	328,000	0	For
WisdomTree	326,022	0	For
Krane Shares Trust	0	297,118	Against
John Hancock	30,500	240,847	Against
Lord Abbett	0	256,213	Against
Baird	0	255,828	Against
First Trust	0	249,459	Against
Northern Trust	0	217,039	Against
NEW ECONOMY FUND	0	186,309	Against
Nationwide	135,500	38,200	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

28. THAT the granting of a share repurchase mandate to the Board of Directors to repurchase an amount of ordinary shares (excluding the Company's ordinary shares listed on the Science and Technology Innovation Board of Shanghai Stock Exchange and traded in RMB ("RMB shares")) and/or ADSs, not exceeding 10% of the total number of issued ordinary shares (excluding RMB shares and treasury shares) of the

CAPITAL STRUCTURE

Combines 5 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 83 asset managers below cast 100% of the shares they voted on this item FOR (73,782,990 for, 0 against).

FOR: 73,782,990 (100.0%)

Largest asset managers voting on “THAT the granting of a share repurchase mandate to the Board of Directors to repurchase an amount of ordinary ” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
BlackRock	944,077	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

29. THAT the members of the Board of Directors and the Executive Management Team be and are hereby discharged from liability for activities during the applicable period under Swiss law.

CORPORATE GOVERNANCE

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 83 asset managers below cast 100% of the shares they voted on this item FOR (73,782,990 for, 0 against).

FOR: 73,782,990 (100.0%)

Largest asset managers voting on “THAT the members of the Board of Directors and the Executive Management Team be and are hereby discharged from” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
BlackRock	944,077	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

30. THAT, on an advisory basis, the Swiss Statutory Non-Financial Matters Report for the fiscal year ended December 31, 2025 be and is hereby approved.

CORPORATE GOVERNANCEENVIRONMENT OR CLIMATEHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCEDIVERSITY, EQUITY, AND INCLUSION

Combines 3 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 83 asset managers below cast 99.9% of the shares they voted on this item FOR (73,716,187 for, 19,300 against).

FOR: 73,716,187 (99.9%)AGAINST: 19,300 (0.0%)ABSTAIN: 47,503 (0.1%)

Largest asset managers voting on “THAT, on an advisory basis, the Swiss Statutory Non-Financial Matters Report for the fiscal year ended Decembe” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
BlackRock	944,077	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

31. THAT the appointment of Ernst & Young LLP, Ernst & Young and Ernst & Young Hua Ming LLP as the Company's independent auditors for the fiscal year ending December 31, 2026 be and is hereby ratified, and Ernst & Young AG be and is hereby re-elected as the Company's statutory auditor for the fiscal year ending December 31, 2026.

AUDIT-RELATED

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 82 asset managers below cast 100% of the shares they voted on this item FOR (73,782,990 for, 0 against).

FOR: 73,782,990 (100.0%)

Largest asset managers voting on “THAT the appointment of Ernst & Young LLP, Ernst & Young and Ernst & Young Hua Ming LLP as the Company's indep” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
Vanguard	29,042,676	For
Capital Group	10,071,735	For
Fidelity	6,806,774	For
TIAA	3,897,446	For
T. Rowe Price	3,268,230	For
Hartford	3,041,800	For
BAILLIE GIFFORD FUNDS	3,010,304	For
Goldman Sachs	1,964,090	For
State Street	1,815,419	For
Delaware/Macquarie	1,783,500	For
PRIMECAP Odyssey Funds	1,246,404	For
Charles Schwab	979,581	For
BlackRock	944,077	For
EUPAC FUND	700,821	For
Dimensional	490,710	For
Pacific Life	328,000	For
WisdomTree	326,022	For
Krane Shares Trust	297,118	For
John Hancock	271,347	For
Lord Abbett	256,213	For
Baird	255,828	For
First Trust	249,459	For
Northern Trust	217,039	For
NEW ECONOMY FUND	186,309	For
Nationwide	173,700	For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

32. If new or modified agenda items (other than those in the invitation to the Annual Meeting and the 2026 Proxy Statement of the Company) or new or modified proposals or motions with respect to the agenda items listed in the invitation to the Annual Meeting and the 2026 Proxy Statement of the Company are presented at the Annual Meeting, I instruct the Independent Voting Representative to vote in favo

CORPORATE GOVERNANCE

Combines 2 wordings of this item as funds reported it.

10% fund support · no official result

10%AGAINST 90%

The 68 asset managers below cast 10% of the shares they voted on this item FOR (7,116,345 for, 60,966,006 against).

FOR: 7,116,345 (10.5%)AGAINST: 60,966,006 (89.5%)ABSTAIN: 741 (0.0%)

Largest asset managers voting on “If new or modified agenda items (other than those in the invitation to the Annual Meeting and the 2026 Proxy S” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
Vanguard	145,950	25,370,533	Against
Capital Group	3,828,746	6,242,989	Against
Fidelity	0	6,806,774	Against
TIAA	0	3,897,446	Against
T. Rowe Price	0	3,268,230	Against
Hartford	0	3,041,800	Against
BAILLIE GIFFORD FUNDS	3,010,304	0	For
Goldman Sachs	0	1,964,090	Against
State Street	0	1,815,419	Against
Delaware/Macquarie	0	1,783,500	Against
Charles Schwab	0	979,581	Against
EUPAC FUND	0	700,821	Against
Dimensional	0	490,710	Against
BlackRock	0	470,400	Against
Pacific Life	0	328,000	Against
WisdomTree	0	326,022	Against
Krane Shares Trust	0	297,118	Against
John Hancock	0	271,347	Against
Lord Abbett	0	256,213	Against
First Trust	0	249,459	Against
Northern Trust	0	217,039	Against
NEW ECONOMY FUND	0	186,309	Against
Nationwide	0	173,700	Against
Morgan Stanley	0	162,325	Against
AMERICAN BEACON FUNDS	0	137,400	Against

Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.

33. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

97% fund support · no official result

FOR 97%

The 12 asset managers below cast 97% of the shares they voted on this item FOR (36,581,758 for, 1,134,881 against).

FOR: 36,581,758 (97.0%)AGAINST: 1,134,881 (3.0%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
BlackRock	35,008,160	0	For
APG Asset Management US Inc.	0	1,134,881	Against
Temasek Holdings (Private) Ltd	862,643	0	For
JPMorgan	469,600	0	For
Empower	156,300	0	For
MASTER INVESTMENT PORTFOLIO	68,369	0	For
Life Cycle Investment Partners Ltd	8,691	0	For
Forethought Variable Insurance Trust	4,100	0	For
TD Waterhouse Canada Inc.	2,033	0	For
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	943	0	For
Qtron Investments LLC	849	0	For
Wilshire Advisors LLC	70	0	For

34. Approve Remuneration Report

SECTION 14A SAY-ON-PAY VOTES

97% fund support · no official result

FOR 97%

The 8 asset managers below cast 97% of the shares they voted on this item FOR (35,715,290 for, 1,134,881 against).

FOR: 35,715,290 (96.9%)AGAINST: 1,134,881 (3.1%)

Largest asset managers voting on “Approve Remuneration Report” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
BlackRock	35,008,160	0	For
APG Asset Management US Inc.	0	1,134,881	Against
JPMorgan	469,600	0	For
Empower	156,300	0	For
MASTER INVESTMENT PORTFOLIO	68,369	0	For
Life Cycle Investment Partners Ltd	8,691	0	For
Forethought Variable Insurance Trust	4,100	0	For
Wilshire Advisors LLC	70	0	For

35. Approve Maximum Aggregate Compensation for Executive Management Team

SECTION 14A SAY-ON-PAY VOTES

95% fund support · no official result

FOR 95%

The 7 asset managers below cast 95% of the shares they voted on this item FOR (23,076,933 for, 1,134,881 against).

FOR: 23,076,933 (95.3%)AGAINST: 1,134,881 (4.7%)

Largest asset managers voting on “Approve Maximum Aggregate Compensation for Executive Management Team” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
BlackRock	21,984,672	0	For
APG Asset Management US Inc.	0	1,134,881	Against
Temasek Holdings (Private) Ltd	862,643	0	For
Empower	156,300	0	For
MASTER INVESTMENT PORTFOLIO	68,369	0	For
Forethought Variable Insurance Trust	4,100	0	For
Qtron Investments LLC	849	0	For

36. Elect Director Elizabeth F. Mooney

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 5 asset managers below cast 100% of the shares they voted on this item FOR (22,215,606 for, 0 against).

FOR: 22,215,606 (100.0%)

Largest asset managers voting on “Elect Director Elizabeth F. Mooney” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
BlackRock	21,986,313	For
Empower	156,300	For
MASTER INVESTMENT PORTFOLIO	68,369	For
Forethought Variable Insurance Trust	4,100	For
Jackson National	524	For

37. Elect Director Margaret Dugan

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 5 asset managers below cast 100% of the shares they voted on this item FOR (22,215,606 for, 0 against).

FOR: 22,215,606 (100.0%)

Largest asset managers voting on “Elect Director Margaret Dugan” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
BlackRock	21,986,313	For
Empower	156,300	For
MASTER INVESTMENT PORTFOLIO	68,369	For
Forethought Variable Insurance Trust	4,100	For
Jackson National	524	For

38. Accept Financial Statements and Statutory Reports

CORPORATE GOVERNANCE

100% fund support · no official result

FOR 100%

The 4 asset managers below cast 100% of the shares they voted on this item FOR (22,213,441 for, 0 against).

FOR: 22,213,441 (100.0%)

Largest asset managers voting on “Accept Financial Statements and Statutory Reports” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
BlackRock	21,984,672	For
Empower	156,300	For
MASTER INVESTMENT PORTFOLIO	68,369	For
Forethought Variable Insurance Trust	4,100	For

39. Adjourn Meeting

CORPORATE GOVERNANCE

99.1% fund support · no official result

FOR 99.1%

The 4 asset managers below cast 99.1% of the shares they voted on this item FOR (22,028,141 for, 185,300 against).

FOR: 22,028,141 (99.2%)AGAINST: 185,300 (0.8%)

Largest asset managers voting on “Adjourn Meeting” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Against	Vote
BlackRock	21,976,072	8,600	For
Empower	0	156,300	Against
MASTER INVESTMENT PORTFOLIO	52,069	16,300	For
Forethought Variable Insurance Trust	0	4,100	Against

40. Amend Omnibus Stock Plan

COMPENSATION

100% fund support · no official result

FOR 100%

The 4 asset managers below cast 100% of the shares they voted on this item FOR (22,213,441 for, 0 against).

FOR: 22,213,441 (100.0%)

Largest asset managers voting on “Amend Omnibus Stock Plan” at BeOne Medicines Ltd., 2025-2026
Asset manager	For	Vote
BlackRock	21,984,672	For
Empower	156,300	For
MASTER INVESTMENT PORTFOLIO	68,369	For
Forethought Variable Insurance Trust	4,100	For

Showing the 40 reported items with the widest manager coverage, of 80 in total. View every item.

Largest BeOne Medicines Ltd. shareholders voting in 2025-2026

Ranked by the number of BeOne Medicines Ltd. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 1,445,262,342 shares outstanding at the time of that meeting.

Top BeOne Medicines Ltd. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	Vanguard	2.68%
2	Capital Group	1.63%
3	Fidelity	1.08%
4	HHLR ADVISORS, LTD.	1.02%
5	BAILLIE GIFFORD OVERSEAS LTD	0.81%
6	State Street	0.79%
7	BAKER BROS. ADVISORS LP	0.62%
8	T. Rowe Price	0.55%
9	Goldman Sachs	0.44%
10	PRIMECAP MANAGEMENT CO/CA/	0.34%

Reported BeOne Medicines Ltd. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

BeOne Medicines Ltd. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
Amgen Inc.	17.04%	DEF14A
Dr. Felix J. Baker	8.02%	DEF14A
Entities affiliated with Baker Bros. Advisors LP	8.02%	DEF14A
Baker Bros. Advisors LP	7.99%	13D
Entities affiliated with Capital International Investors	5.65%	DEF14A
Mr. John V. Oyler	4.56%	DEF14A
Capital International Investors	4.51%	13G
Dr. Xiaodong Wang	1.03%	DEF14A
Dr. Lai Wang	0.30%	DEF14A
Dr. Xiaobin Wu	0.16%	DEF14A

Percentages above are of 1,445,262,342 shares outstanding, as reported by BeOne Medicines Ltd. on its Form 10-Q dated 2026-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BeOne Medicines Ltd.’s 10-Q dated 2026-04-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At BeOne Medicines Ltd.'s shareholder meeting held 2026-06-11, in the 2025-2026 proxy season, 404 asset managers reported how they voted in their SEC Form N-PX filings, covering 9,277 separate fund positions. Their filings are grouped here into 80 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. BeOne Medicines Ltd.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — THAT, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE… — the reporting funds cast 85% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

BeOne Medicines Ltd. proxy season coverage: 2025-2026 (this page).